老年心血管病患者的他汀治疗
摘要
过去10年中,国内外先后完成了一系列里程碑式的降脂试验,这些研究结果有力论证了应用他汀降胆固醇治疗在冠心病及相关心血管疾病一、二级预防中的重要意义。
出处
《实用老年医学》
CAS
2011年第5期353-356,共4页
Practical Geriatrics
参考文献10
-
1Ford ES,Mokdad AH,Giles WH,et al.Serum total cholesterol concentrations and awareness,treatment,and control of hyprecholesterolemia among US adults:findings from the national health and nutrition examination survey,1999 to 2000[J].Circulation, 2003,107 (5):2185-2189.
-
2Grundy SM.The role of cholesterol management in coronary disease risk reduction in elderly patients[J].Endocrinol Metab Clin North Am,1998,27(3):655-675.
-
3Shepherd J,Cobbe SM,Ford I,et al.Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia[J].N Engl J Med,1995,333(20):1301-1307.
-
4Downs JR,Clearfield M,Weis S,et al.Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels:results of AFCAPS/TexCAPS.Air Force/Texas Coronary Atherosclerosis Prevention Study[J].JAMA,1998,279 (20):1615-1622.
-
5Scandinavian Simvastatin Survival Study Group.Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease:the Scandinavian Simvastatin Survival Study (4S)[J].Lancet,1994,344(8934):1383-1389.
-
6Sacks FM,Pfeffer MA,Moye LA,et al.The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels.Cholesterol and Recurrent Events Trial investigators[J].N Engl J Med,1996,335 (14):1001-1009.
-
7The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group.Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels[J].N Engl J Med,1998,339(19):1349-1357.
-
8Heart Protection Study Collaborative Group.MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals:a randomised placebo-controlled trial[J].Lancet,2002,360 (9326):7-22.
-
9Shepherd J,BlauwGJ,MurphyMB,et al.Pravastatin in elderly individuals at risk of vascular disease (PROSPER):a randomised controlled trial[J].Lancet,2002,360(9346):1623-1630.
-
10杜保民,陆宗良,武阳丰,叶平,陈祚.中国冠心病二级预防研究——老年高血压人群的干预结果分析[J].中华老年心脑血管病杂志,2006,8(2):82-86. 被引量:17
二级参考文献7
-
1血脂康调整血脂对冠心病二级预防研究协作组.中国冠心病二级预防研究[J].中华心血管病杂志,2005,33(2):109-115. 被引量:222
-
2陆宗良,杜保民,武阳丰,陈祚.血脂康对老年人冠心病二级预防的作用[J].中华老年医学杂志,2005,24(11):805-808. 被引量:22
-
3Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering on 4444 patients with coronary heart disease: the Scandinavian simvastatin survival study (4S) [J]. Lancet, 1994, 344:1383-1389.
-
4Sacks FM, Pfeffer MA, Moye LA, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels[J]. N Engl J Med, 1996,335 : 1001-1009,
-
5The Lipid Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels[ J ]. N Engl J Med, 1998,339:1349-1357.
-
6Shepherd J, Blauw GJ, Murphy MB, et al. Pravastatin in elderly individuals at risk of vascular disease(PROSPER) : a randomized controlled trial[J] .The Lancet,2002,360:1623-1630.
-
7Li ZP. Cholesterol-lowering effects and pharmacokinetics of Chinese red yeast rice[A]. In: Inaugural international congress on complementary and alternative medicine[ M ]. Singapore: Raffles City Convention Centre, 2005.94.
共引文献16
-
1Jing Luo,Hao Xu,Ke-Ji Chen.Potential benefits of Chinese Herbal Medicine for elderly patients with cardiovascular diseases[J].Journal of Geriatric Cardiology,2013,10(4):305-309. 被引量:1
-
2关绍晨,汤哲,李静,吴晓光,刁丽军,刘宏军,孙菲,方向华.老年人血压水平与冠心病和脑卒中发病关系的研究[J].中华老年心脑血管病杂志,2007,9(3):166-169. 被引量:27
-
3顾言,陈佳漪,王芳.2000~2006年老年患者2798例急诊抢救特点调查分析[J].南通大学学报(医学版),2007,27(5):393-394. 被引量:2
-
4曹选成,李晟,秦莉花,陈晓阳,程丑夫.冠心病危险因素的调查研究[J].中国现代医药杂志,2007,9(12):13-15. 被引量:6
-
5韦方,任正兴,王树辉,李宗庄.血脂康对冠心病患者循环内皮细胞及炎性相关因子水平的影响[J].贵州医药,2008,32(1):33-34. 被引量:1
-
6武重阳.关于中医药在冠心病二级预防中的模式思考[J].时珍国医国药,2009,20(11):2903-2904. 被引量:1
-
7植绍权.急诊抢救危重病1140例临床分析[J].亚太传统医药,2010,6(8):106-107. 被引量:4
-
8郑平.老年冠心病患者的健康教育[J].中国医药指南,2010,8(35):251-252.
-
9韦方,周永刚,李安洁,王树辉,袁军.血脂康对急性冠脉综合征患者淋巴细胞亚群的影响[J].贵州医药,2012,36(1):1-3. 被引量:3
-
10吴艳梅.冠心病传统心血管病危险因素的评价[J].宁夏医学杂志,2012,34(5):443-446. 被引量:2
-
1许利.药物降胆固醇治疗中10个最常见的问题[J].中国社区医师(医学专业),2004,6(12):2-5.
-
2郭艺芳,胡大一.老年患者的他汀类药物降胆固醇治疗[J].中华内科杂志,2007,46(11):893-894. 被引量:5
-
3胆固醇吸收抑制剂临床应用中国专家共识在北京发布[J].中国医药导刊,2010,12(2):308-308.
-
4非他汀类药物可降低心血管病风险[J].医药前沿,2015,5(24):2-2.
-
5刘洪涛,连玉菲,庞国勋,靳会欣,任炳楠,董占军.临床药师参与1例老年心血管病患者的个体化抗血小板治疗实践[J].药学与临床研究,2016,24(2):170-171. 被引量:5
-
6研究证实非他汀类药物可降低心血管病风险[J].医院与医学,2015,3(2):18-18.
-
7阿斯利康和雅培公司计划联合开发复方降胆固醇药物[J].中华医学信息导报,2006,21(15):17-17.
-
8李景香,王士玲.老年心血管病患者的护理[J].现代医药卫生,2005,21(12):1591-1592. 被引量:5
-
9朱园园(摘).AEGR733为降低胆固醇提供新思路[J].国外药讯,2008(3):12-12.
-
10朱国英.预防冠心病,8岁开始服他汀?[J].家庭医药(就医选药),2009(9):26-26.